| Profile | GDS1873 / 213113_s_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 211.455 | 56 |
| GSM40788 | control - Rep 2 | 282.128 | 63 |
| GSM40789 | control - Rep 3 | 246.12 | 60 |
| GSM40775 | androgen treated - Rep 1 | 298.673 | 65 |
| GSM40776 | androgen treated - Rep 2 | 236.982 | 59 |
| GSM40777 | androgen treated - Rep 3 | 256.99 | 61 |
| GSM40790 | estrogen treated - Rep 1 | 269.083 | 62 |
| GSM40791 | estrogen treated - Rep 2 | 215.033 | 56 |
| GSM40792 | estrogen treated - Rep 3 | 226.546 | 57 |
| GSM40784 | A + tamoxifen - Rep 1 | 257.755 | 61 |
| GSM40785 | A + tamoxifen - Rep 2 | 283.551 | 63 |
| GSM40786 | A + tamoxifen - Rep 3 | 256.969 | 61 |
| GSM40778 | A + anastrozole - Rep 1 | 281.846 | 64 |
| GSM40779 | A + anastrozole - Rep 2 | 204.391 | 54 |
| GSM40780 | A + anastrozole - Rep 3 | 250.177 | 60 |
| GSM40781 | A + letrozole - Rep 1 | 315.717 | 67 |
| GSM40782 | A + letrozole - Rep 2 | 223.864 | 57 |
| GSM40783 | A + letrozole - Rep 3 | 242.452 | 59 |